238 related articles for article (PubMed ID: 9290705)
41. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
[TBL] [Abstract][Full Text] [Related]
42. Microsatellite instability in uterine sarcomas.
Amant F; Dorfling CM; Dreyer L; Vergote I; Lindeque BG; Van Rensburg EJ
Int J Gynecol Cancer; 2001; 11(3):218-23. PubMed ID: 11437928
[TBL] [Abstract][Full Text] [Related]
43. Uterine leiomyosarcomas and benign smooth muscle tumors: usefulness of nuclear DNA patterns studied by flow cytometry.
Tsushima K; Stanhope CR; Gaffey TA; Lieber MM
Mayo Clin Proc; 1988 Mar; 63(3):248-55. PubMed ID: 3343869
[TBL] [Abstract][Full Text] [Related]
44. Structural aberrations of chromosome 6 in three uterine smooth muscle tumors.
Hennig Y; Deichert U; Stern C; Ghassemi A; Thode B; Bonk U; Meister P; Bartnitzke S; Bullerdiek J
Cancer Genet Cytogenet; 1996 Apr; 87(2):148-51. PubMed ID: 8625261
[TBL] [Abstract][Full Text] [Related]
45. MRI findings in-between leiomyoma and leiomyosarcoma: a Rad-Path correlation of degenerated leiomyomas and variants.
Bura V; Pintican RM; David RE; Addley HC; Smith J; Jimenez-Linan M; Lee J; Freeman S; Georgiu C
Br J Radiol; 2021 Sep; 94(1125):20210283. PubMed ID: 34289327
[TBL] [Abstract][Full Text] [Related]
46. No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas.
Barker KT; Spendlove HE; Banu NS; Bridge JA; Fisher C; Shipley J; Garrett M; Manyonda I; Houlston RS
Cancer Lett; 2006 Apr; 235(1):136-40. PubMed ID: 15949892
[TBL] [Abstract][Full Text] [Related]
47. Complex chromosome rearrangements involving 12q14 in two uterine leiomyomas.
Pandis N; Bardi G; Sfikas K; Panayotopoulos N; Tserkezoglou A; Fotiou S
Cancer Genet Cytogenet; 1990 Oct; 49(1):51-6. PubMed ID: 2397473
[TBL] [Abstract][Full Text] [Related]
48. Cytogenetics of multiple uterine leiomyomas, parametrial leiomyoma and disseminated peritoneal leiomyomatosis.
Mark J; Havel G; Dahlenfors R; Wedell B
Anticancer Res; 1991; 11(1):33-9. PubMed ID: 2018368
[TBL] [Abstract][Full Text] [Related]
49. MED12 mutations in leiomyosarcoma and extrauterine leiomyoma.
Ravegnini G; Mariño-Enriquez A; Slater J; Eilers G; Wang Y; Zhu M; Nucci MR; George S; Angelini S; Raut CP; Fletcher JA
Mod Pathol; 2013 May; 26(5):743-9. PubMed ID: 23222489
[TBL] [Abstract][Full Text] [Related]
50. t(10;17) as the sole chromosome change in a uterine leiomyosarcoma.
Dal Cin P; Boghosian L; Crickard K; Sandberg AA
Cancer Genet Cytogenet; 1988 Jun; 32(2):263-6. PubMed ID: 3163264
[TBL] [Abstract][Full Text] [Related]
51. Molecular and cytogenetic analysis of chromosome 7 in uterine leiomyomas.
Ishwad CS; Ferrell RE; Davare J; Meloni AM; Sandberg AA; Surti U
Genes Chromosomes Cancer; 1995 Sep; 14(1):51-5. PubMed ID: 8527384
[TBL] [Abstract][Full Text] [Related]
52. Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas.
Meza-Zepeda LA; Kresse SH; Barragan-Polania AH; Bjerkehagen B; Ohnstad HO; Namløs HM; Wang J; Kristiansen BE; Myklebost O
Cancer Res; 2006 Sep; 66(18):8984-93. PubMed ID: 16982739
[TBL] [Abstract][Full Text] [Related]
53. Association of the shrinkage of uterine leiomyoma treated with GnRH agonist and deletion of long arm of chromosome 7.
Takahashi K; Kawamura N; Tsujimura A; Ichimura T; Ito F; Ishiko O; Ogita S
Int J Oncol; 2001 Jun; 18(6):1259-63. PubMed ID: 11351260
[TBL] [Abstract][Full Text] [Related]
54. Different methylation levels in the KLF4, ATF3 and DLEC1 genes in the myometrium and in corpus uteri mesenchymal tumours as assessed by MS-HRM.
Braný D; Dvorská D; Grendár M; Ňachajová M; Szépe P; Lasabová Z; Žúbor P; Višňovský J; Halášová E
Pathol Res Pract; 2019 Aug; 215(8):152465. PubMed ID: 31176573
[TBL] [Abstract][Full Text] [Related]
55. Molecular differential diagnosis of uterine leiomyomas and leiomyosarcomas.
Mas A; Simón C
Biol Reprod; 2019 Dec; 101(6):1115-1123. PubMed ID: 30184111
[TBL] [Abstract][Full Text] [Related]
56. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression.
Hodge JC; Morton CC
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R7-13. PubMed ID: 17613550
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of occult leiomyosarcomas and atypical leiomyomas after laparoscopic morcellation of leiomyomas in reproductive-age women.
Pados G; Tsolakidis D; Theodoulidis V; Makedos A; Zaramboukas T; Tarlatzis B
Hum Reprod; 2017 Oct; 32(10):2036-2041. PubMed ID: 28938732
[TBL] [Abstract][Full Text] [Related]
58. Characterization of uterine leiomyomas by whole-genome sequencing.
Mehine M; Kaasinen E; Mäkinen N; Katainen R; Kämpjärvi K; Pitkänen E; Heinonen HR; Bützow R; Kilpivaara O; Kuosmanen A; Ristolainen H; Gentile M; Sjöberg J; Vahteristo P; Aaltonen LA
N Engl J Med; 2013 Jul; 369(1):43-53. PubMed ID: 23738515
[TBL] [Abstract][Full Text] [Related]
59. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases.
Lee TK; Miyamoto H; Osunkoya AO; Guo CC; Weiss SW; Epstein JI
Am J Surg Pathol; 2010 Apr; 34(4):502-9. PubMed ID: 20154594
[TBL] [Abstract][Full Text] [Related]
60. Expression of CD44 standard and isoforms V3 and V6 in uterine smooth muscle tumors: a possible diagnostic tool for the diagnosis of leiomyosarcoma.
Poncelet C; Walker F; Madelenat P; Bringuier AF; Scoazec JY; Feldmann G; Darai E
Hum Pathol; 2001 Nov; 32(11):1190-6. PubMed ID: 11727257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
